GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Interest Expense

Guanhao Biotech Co (SZSE:300238) Interest Expense : ¥-0.9 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Guanhao Biotech Co's interest expense for the three months ended in Sep. 2024 was ¥ -0.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Guanhao Biotech Co's Operating Income for the three months ended in Sep. 2024 was ¥ 6.6 Mil. Guanhao Biotech Co's Interest Expense for the three months ended in Sep. 2024 was ¥ -0.1 Mil. Guanhao Biotech Co's Interest Coverage for the quarter that ended in Sep. 2024 was 44.69. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Guanhao Biotech Co Interest Expense Historical Data

The historical data trend for Guanhao Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Interest Expense Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.78 -14.58 -7.36 -4.11 -1.78

Guanhao Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.37 -0.39 -0.16 -0.15 -0.15

Guanhao Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanhao Biotech Co  (SZSE:300238) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Guanhao Biotech Co's Interest Expense for the three months ended in Sep. 2024 was ¥-0.1 Mil. Its Operating Income for the three months ended in Sep. 2024 was ¥6.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ¥70.4 Mil.

Guanhao Biotech Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*6.57/-0.147
=44.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Guanhao Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Interest Expense
Comparable Companies
SHSE:688488 SHSE:688238 SZSE:300404 BJSE:430047 SHSE:688767 SZSE:300149 SHSE:688089 SZSE:003020 SZSE:300381 SZSE:300942 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Website
http://www.grandhopebio.com
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co Headlines

No Headlines